Dynamic Neural Systems Underlying Social-emotional Functions in Older Adults
Launched by UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · Dec 7, 2022
Trial Information
Current as of February 05, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a digital meditation program delivered through an app can help improve the emotional well-being of lonely older adults. Researchers are particularly interested in understanding how this meditation affects the brain and body by using advanced imaging techniques. If you're an older adult aged 60 or over, fluent in English, and have little to no experience with meditation, you may be eligible to participate.
Participants in the trial will engage in meditation through the app while researchers monitor their emotional responses and brain activity. It's important to note that individuals with certain medical conditions, severe mental health issues, or those who have previously meditated regularly are not eligible. This study aims to provide insights into how meditation may help reduce feelings of loneliness and improve emotional health in older adults.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 60 years of age or older
- • English language fluency
- • Naive to meditation practices (not actively meditating more than one hour per month and/or meditation practice for less than a year in their entire life-time)
- • No MRI contra-indications
- • Cognitively healthy (no diagnosis of dementia, stroke, developmental disorders, or major systemic diseases that may impact cognitive function)
- Exclusion Criteria:
- • Below 60 years of age
- • Not fluent in English
- • Active meditator (meditating more than one hour per month and/or meditation practice for more than a year in their entire life-time).
- • Presence of a severe psychiatric (e.g. schizophrenia, bipolar disorder, PTSD), neurological (epilepsy, traumatic brain injury, dementia, multiple sclerosis), or developmental disorder (e.g. autism)
- • Systemic disease (e.g. major recent surgeries, cancer)
- • Claustrophobia
- • Contraindications for MR safety (e.g. metal in body, cochlea implants)
Trial Officials
Lorenzo Pasquini, PhD
Principal Investigator
University of California, San Francisco
About University Of California, San Francisco
The University of California, San Francisco (UCSF) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on translating scientific discoveries into effective therapies, UCSF collaborates with a diverse array of stakeholders, including healthcare professionals, industry partners, and patient communities. The university's research programs emphasize interdisciplinary approaches and leverage cutting-edge technology to address complex medical challenges. As a sponsor of clinical trials, UCSF is dedicated to maintaining the highest standards of ethical conduct and scientific rigor, ensuring the safety and well-being of participants while contributing to the broader medical knowledge base.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Francisco, California, United States
San Francisco, California, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials